It has been well documented that the endoplasmic reticulum (ER) responds to cellular stresses through the unfolded protein response (UPR), but it is unknown how the Golgi responds to similar stresses. In this study, we treated HeLa cells with ER stress inducers, thapsigargin (TG), tunicamycin (Tu) and Dithiothreitol (DTT), and found that only TG treatment caused Golgi fragmentation. TG induced Golgi fragmentation at a low dose and short time when UPR was undetectable, demonstrating that Golgi fragmentation occurs independently of ER stress. Further experiments demonstrated that TG induces Golgi fragmentation through elevated intracellular Ca 2+ and protein kinase Cα (PKCα) activity, which phosphorylates the Golgi stacking protein GRASP55. Significantly, activation of PKCα with other activating or inflammatory agents, including Phorbol 12-myristate 13-acetate (PMA) and histamine, modulates the Golgi structure in a similar fashion. Hence, our study revealed a novel mechanism through which increased cytosolic Ca 2+ modulates Golgi structure and function.
INTRODUCTION
In mammalian cells, the Golgi apparatus is characterized by a multilayer stacked structure of ~5-7 flattened cisternal membranes, and stacks are often laterally linked to form a ribbon located in the perinuclear region of the cell (1). The exact mechanism of Golgi stack formation is not fully understood, but it has been shown that the Golgi re-assembly stacking protein of 55 kDa (GRASP55, also called GORASP2) and its homolog GRASP65 (GORASP1) play essential roles in Golgi stacking (2, 3) . Both GRASPs are peripheral membrane proteins that share similar domain structures and overlapping functions (4) . GRASP65 is predominantly concentrated in the cis Golgi, whereas GRASP55 is localized on medial-trans cisternae. Both GRASPs form trans-oligomers through their Nterminal GRASP domains that "glue" adjacent Golgi cisternae together into stacks (2, 5) and ribbons (6) (7) (8) . GRASP oligomerization is regulated by phosphorylation; mitotic phosphorylation of GRASP55 and GRASP65 at the C-terminal Serine/ Proline-Rich (SPR) domain inhibits its oligomerization and results in Golgi cisternal unstacking and disassembly (5, 9) .
The Golgi exhibits different morphology in different cell types and tissues as well as under different conditions. For example, in many secretory cells such as Brunner's gland of platypus, the Golgi forms large, well-formed stacks (10) . A plausible hypothesis is that the Golgi adjusts its structure and function in response to different physiological and pathological conditions. For instance, increased neuronal activity causes dispersal of the Golgi at the resolution of light microscopy (11) , while electron micrographs show reorganization of Golgi membranes in prolactin cells of female rats upon cessation of a sucking stimulus (12) . In Alzheimer's disease, the Golgi membranes are dispersed and fragmented in neurons from human brain and mouse models (13) . Golgi fragmentation is also observed in other neurodegenerative diseases, including Parkinson's (14) and Huntington's (15) diseases and amyotrophic lateral sclerosis (ALS) (16) (17) (18) . In addition, the Golgi has also been shown to be fragmented in lung, prostate and breast cancers (19) (20) (21) . The molecular mechanisms that control Golgi structure and function under disease conditions are so far not well understood.
The Golgi structure can be modulated experimentally such as by molecular manipulations of GRASP55 and GRASP65. Microinjection of antibodies against GRASP55 or GRASP65 into cells inhibits post-mitotic stacking of newly formed Golgi cisternae (2) . Knockdown (KD, by siRNA) or knockout (KO, by CRISPR/Cas9) of either GRASP reduces the number of cisternae per stack (22, 23) , whereas simultaneous depletion of both GRASPs causes fragmentation of the entire Golgi stack (5, 24) . Expression of non-phosphorylatable GRASP65 mutants enhances Golgi stacking in interphase and inhibited Golgi disassembly in mitosis (23) . Since GRASPs play critical roles in Golgi structure formation, it is reasonable to speculate that physiological and pathological cues may trigger Golgi fragmentation through GRASP55/65 modification, such as phosphorylation (25) . Using GRASPs as tools to manipulate Golgi stack formation, it has been demonstrated that Golgi cisternal unstacking accelerates protein trafficking, but impairs accurate glycosylation and sorting (24, 26) . In addition, GRASP depletion also impacts other cellular activities such as cell attachment, migration, growth, and autophagy (27, 28) .
Protein kinase C (PKC) is a large family of multifunctional serine/threonine kinases that are activated by signals such as increases in the concentration of diacylglycerol (DAG) and/or calcium ions (Ca 2+ ) within the cell. In cells, PKCs are mainly cytosolic, but transiently localize to membranes, such as endosomes and Golgi, upon activation (29, 30) . Membrane association of PKC is via a C1 domain that interacts with DAG present in the membrane. Conventional PKCs (cPKCs) also contain a C2 domain that binds Ca 2+ ions, which further enhances their membrane association and activity (31) . Knockdown of atypical PKCs (aPKCs) using siRNA causes a reduction in peripheral ERGIC-53 clusters without affecting the Golgi morphology (32) . In addition, increased PKC activity has been implicated in cancer (33, 34) , but the mechanism by which PKC may contribute to invasion, inflammation, tumorigenesis, and metastasis is not fully understood (35) .
In this study, we performed high-resolution microscopy and biochemistry experiments to determine how the Golgi responds to cellular stresses such as ER stress. While not all ER stress inducers caused Golgi fragmentation, treatment of cells with the Ca 2+ -ATPase inhibitor thapsigargin (TG) resulted in Golgi fragmentation with a low dose and short time in which ER stress was undetectable, indicating that Golgi fragmentation occurs independently of ER stress. Further experiments demonstrated that TG-induced cytosolic Ca 2+ spikes activate PKC that phosphorylates GRASP55. Interestingly, inflammatory factors such as histamine modulate the Golgi structure through a similar mechanism. Thus, we have uncovered a novel pathway through which cytosolic Ca 2+ modulates the Golgi structure and function.
RESULTS

TG induces Golgi fragmentation and UPR
It has been hypothesized that ER stress and the unfolded protein response (UPR) cause Golgi fragmentation and dysfunction through overloading misfolded proteins into the Golgi (36) . To test this hypothesis, we performed a time course treatment of HeLa cells with a well-known UPR inducer, TG, which specifically blocks the sarcoendoplasmic reticulum Ca 2+ transport ATPase (SERCA) (37) and causes Ca 2+ dysregulation (38) . We assessed the Golgi morphology by co-staining the cells for GM130, a cis-Golgi marker, and TGN46, a protein in the trans-Golgi network. As shown in Fig. 1A-B , the Golgi became fragmented after TG treatment, and the response was linear over time ( Fig. 1A-B ; Fig. S1A ). Although Golgi fragmentation was more obvious after a longer treatment, it became detectable in shorter treatments such as 10 min. More careful examination of the Golgi morphology by super-resolution fluorescence microscopy demonstrated that the Golgi ribbon was broken down, as the Golgi exhibited as disconnected puncta in the cell. The stacks were also defective, as indicated by the separation of GM130 and TGN46 signals ( Fig. 1C -D).
To correlate Golgi fragmentation with UPR, we performed Western blot of TG-treated cells to assess the levels of several UPR markers, including phosphorylated eukaryotic translation initiation factor 2A eIF2α (p-eIF2α), the ER UPR chaperone binding of immunoglobulin protein (Bip), and the CCAATenhancer-binding protein homologous protein (CHOP). As shown in Fig. 1E -G, longer term TG treatment, such as 2 h or longer, caused UPR, as indicated by the increase of all three markers. When the treatment was reduced to 30 min, only the p-eIF2α level increased, while Bip and CHOP did not change. This indicates that the minimal time for UPR to occur is ~30 min under our experimental conditions. Consistently, no significant increase in the level of any of these UPR markers was detected when the treatment was reduced to below 30 min. Interestingly, the Golgi in a significant proportion of cells was fragmented at this time. Golgi fragmentation was obvious with 10 min TG treatment when UPR was undetectable, and became more prevalent at 30 min treatment ( Fig. 1A-B ). The fact that Golgi fragmentation occurs earlier than UPR indicates that Golgi fragmentation is unlikely a side effect of ER stress, but rather, occurs independently of UPR.
It is worth mentioning that TG treatment did not affect the level of key Golgi structural proteins, including the Golgi stacking proteins GRASP55 and GRASP65, Golgi tethering proteins GM130 and p115, and the Golgi SNARE Gos28 (Fig. 1E ), indicating that TG induces Golgi fragmentation likely 6 through modification rather than degradation of Golgi structural proteins. In addition, TG-induced Golgi fragmentation is reversible; when TG was washed out, the Golgi structure gradually returned to its normal shape ( Fig. S1B-D) . Consistently, TG-treatment did not induce apoptosis as shown by Annexin V staining. In contrast, staurosporine treatment, which is known to induce apoptosis, increased Annexin V cell surface staining ( Fig. S1D -E).
Tunicamycin (Tu) or Dithiothreitol (DTT) treatment induces UPR but not Golgi fragmentation
To test whether the hypothesis that Golgi fragmentation occurs independently of ER stress applies only to TG treatment or also to other ER stress inducers, we repeated the same set of experiments by treating cells with Tunicamycin (Tu), an antibiotic that induces ER stress by inhibiting N-glycosylation and by the accumulation of misfolded proteins in the ER lumen. 6 h Tu treatment increased the width of the ER cisternae and caused ER fragmentation ( Fig. S1F ). However, this treatment did not affect the Golgi morphology after 360 min, as indicated by the GM130 and TGN46 signals ( 
TG induces Golgi fragmentation prior to UPR through elevated cytosolic Ca 2+
We next sought to decouple the Golgi stress response from UPR after TG treatment. As a complimentary approach to the time-course experiment shown in Fig. 1 , we titrated TG (1 -250 nM) in the treatment. Here we treated cells for 20 min, a time point prior to UPR becoming detectable when cells were treated with 250 nM TG (Fig. 1) . The results showed that Golgi fragmentation increased linearly in response to the increasing TG concentration, and importantly, TG at low doses (1 nM to 250 nM) effectively caused Golgi fragmentation ( Fig. 2A-B ). For comparison, we also assessed UPR in the same cells. As shown in Fig. 2C -E, treatment of cells with up to 250 nM TG for 20 minutes did not cause UPR as indicated by the p-eIF2α and Bip levels.
We next asked how TG treatment induces Golgi fragmentation. Knowing that TG increases cytosolic Ca 2+ (39), we employed the membrane permeable Ca 2+ chelater BAPTA-AM to test whether TG induces Golgi fragmentation through cytosolic Ca 2+ . We pre-treated cells with BAPTA-AM alone (60 µM) for 30 min, and then with or without TG (100 nM) for 0, 15, 30, and 60 min ( Fig. 2F -G). The result showed that BAPTA-AM significantly prevented TG-induced Golgi fragmentation, while BAPTA-AM alone did not affect the Golgi morphology. Subsequent EM analysis confirmed TGinduced Golgi fragmentation and rescue by BAPTA-AM ( Fig. 2H-I) . TG treatment reduced the number of cisternae per stack and the length of cisternae, but increased the number of vesicles surrounding each stack. These effects were largely abolished by the addition of BAPTA-AM. These results demonstrated that cytosolic Ca 2+ is required for TG-induced Golgi fragmentation. Consistent with this notion, treatment of cells with a Ca 2+ ionophore, ionomycin (Io), also caused Golgi fragmentation ( Fig. S4A-B ). Therefore, the driving force behind TG-induced Golgi fragmentation is the increased cytosolic Ca 2+ .
TG-induced Golgi fragmentation increases protein trafficking in the Golgi
As GRASP depletion-mediated Golgi destruction impacts Golgi functions such as protein trafficking (26, 27) , we examined the effect of TG treatment on the trafficking of the Vesicular Stomatitis Virus Glycoprotein (VSV-G) using the well-established RUSH system (40) . Cells were transfected with a plasmid that encodes both the invariant chain of the major histocompatibility complex (Ii, an ER protein) fused to core streptavidin and VSV-G fused to streptavidin-binding peptide (SBP). Under growth conditions without biotin, the interaction between streptavidin and SBP retains VSV-G in the ER. Upon the addition of biotin, this interaction is disrupted, resulting in synchronous release of the VSV-G reporter from the ER to the Golgi. Since VSV-G is a glycoprotein, we used endoglycosidase H (EndoH) to distinguish its core (ER and cis Golgi) and complex (trans Golgi and post-Golgi) glycosylation forms as an indicator of trafficking. As shown in Fig. 3A , TG treatment first slightly decreased VSV-G trafficking at 15 min release, but then increased VSV-G trafficking at 60 and 90 min compared to DMSO control. Our previous studies showed that VSV-G reaches the cis Golgi at 15-20 min and trans Golgi at ~90 min (24, 41) . These results suggest that TG treatment may delay VSV-G release possibly by slowing down its folding; but once it reaches the cis Golgi, VSV-G trafficking across the Golgi stack is significantly accelerated. Monensin is known to disrupt the Golgi structure and blocks TGN exit, and thus was used as a control (42) . As expected, monensin treatment resulted in VSV-G accumulation in the Golgi (Fig. 3A -C).
To confirm these results using an alternative approach, we treated cells with Brefeldin A (BFA) to accumulate ManII-GFP in the ER. We then washed out BFA and analyzed ManII-GFP in ER-to-Golgi trafficking. The results showed that ManII-GFP started to accumulate in the Golgi at 60 min BFA washout in the presence of TG, while the same observation occurs at 90 min in the control (Fig. 3D ).
TG induces Golgi fragmentation through PKCα activation
Given that phosphorylation of Golgi structural proteins has been shown to cause Golgi fragmentation in physiological conditions such as in mitosis (2, 5, 23) , as well as in pathological conditions such as in Alzheimer's disease (43) , we explored the possibility that phosphorylation of Golgi structural proteins may play a role in TG-induced Golgi fragmentation. We treated cells with staurosporine, a nonselective kinase inhibitor, and a number of specific inhibitors of calcium-related kinases such as protein kinase Cs (PKCs) and Ca 2+ /calmodulin-dependent protein kinases (CAMKs). As shown in Fig inhibited TG-induced Golgi fragmentation effectively, KN-62 had no effect ( Fig. 4A-B ), suggesting a major role of PKC in TG-induced Golgi fragmentation.
To further confirm that PKC activation causes Golgi fragmentation, we treated cells with Phorbol 12myristate 13-acetate (PMA), a widely used PKC activator, and its inactive enantiomer, 4-alpha-phorbol myristate acetate (4-alpha). The results showed that PMA treatment caused Golgi fragmentation, while 4-alpha had no effect ( Fig. 4C-D ). In addition, expression of CAMKIIβ had no effect on the Golgi morphology ( Fig. S4E-F ). There have been reports that activation of MAPK/ERK or PKD signaling causes Golgi fragmentation (44, 45) , we therefore inhibited these two kinases with U0126 or H-89, respectively. Pre-treatment of cells with these kinase inhibitors did not prevent Golgi fragmentation upon the addition of TG ( Fig. S4G-H) . Taken together, these results indicate that TG induces Golgi fragmentation through PKC activation.
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PKC has multiple isoforms including α, βI, βII, γ, δ, ε, η, ζ, and ι (46) . To identify the PKC isoform responsible for TG-induced Golgi fragmentation, we expressed GFP-tagged PKC isoforms, including all four known classical PKC (cPKC) isozymes (α, βI, βII, γ) that respond to Ca 2+ stimuli, one from the non-calcium responsive novel PKC (nPKC, δ), and one from the atypical PKC (nPKC, ζ) subfamily ( Fig. S5A-B) . To enhance the activity of expressed PKC, we also treated cells with PMA, and with 4alpha as a control. The results showed that expression of PKCα and treatment of cells with PMA increased Golgi fragmentation ( Fig. 4E -G; Fig. S5A-B ). Interestingly, PKCα-GFP is concentrated on the Golgi upon PMA treatment, as indicated by the colocalization with GM130; while other PKC isoforms did not show the same phenotype (Fig. 4E; Fig. S5B ). To further specify that PKCα mediates TG-induced Golgi fragmentation, we knocked down PKCα in cells with siRNA. The results showed that PKCα depletion reduces Golgi fragmentation after TG treatment ( Fig. 4H-J) . Taken together, these results demonstrate that PKCα activation causes Golgi fragmentation.
PKCα induces Golgi fragmentation through GRASP55 phosphorylation
Since activated PKCα localizes to the Golgi, we thought it might phosphorylate Golgi structural proteins. To identify potential PKCα targets on the Golgi, we performed gel mobility shift assays on a number of Golgi structural proteins, tethering factors, and SNARE proteins after TG treatment ( Fig.   S5C ). To ensure that the band shift was caused by phosphorylation, we also applied staurosporine (2 µM for 10 min prior to TG treatment) to TG-treated cells to broadly inhibit phosphorylation. Among the proteins tested, GRASP55 and GRASP65 showed a smear above the main bands ( Fig. S5C ), indicating a partial phosphorylation of the proteins. To increase the resolution of phosphorylated proteins we utilized Phos-tag gels, which showed GRASP55, but not GRASP65, to be significantly shifted up after TG treatment (250 nM, 1 h) ( Fig. S5D ). TG-induced mobility shift of GRASP55 was not seen upon Tu treatment (Fig. 5A, lanes 2 vs. 3 ). The shift induced by TG treatment was less dramatic than by nocodazole, which blocks cells from exiting mitosis ( GRASP55 contains an N-terminal GRASP domain that forms dimers and oligomers, and a C-terminal serine/proline-rich (SPR) domain with multiple phosphorylation sites (3, 5) . To map the PKCα phosphorylation site on GRASP55, we expressed GFP-tagged GRASP55 truncation mutants (47) , treated the cells with TG, and determine their phosphorylation. A visible mobility shift of the GRASP55 variants was observed on the mutants possessing amino acids (aa)251-454, but not the truncated forms shorter than aa250 ( Fig. 5D -E). To further determine the functional consequence of GRASP55 phosphorylation, we expressed these constructs and treated cells with TG. The exogenously expressed GRASP55 truncation mutants were targeted to the Golgi, but had no impact on the Golgi structure ( Fig. S5E ). However, when cells were treated with TG, expression of the N-terminal aa250 or shorter reduced TG-induced Golgi fragmentation; while expression of N-terminal aa300 or longer had no significant effect ( Fig. 5F-G) . These results demonstrated that phosphorylation of GRASP55 within aa251-300 is important for TG-induced Golgi fragmentation.
Histamine modulates the Golgi structure through the same pathway as TG treatment
It is known that histamine activates Ca 2+ -dependent PKC isoforms and up-regulates cytokine secretion via the release of calcium from the ER into the cytosol (48) . It has also been shown that histamine triggers protein secretion and Golgi fragmentation (49) , but the underlying mechanism has not been revealed. Therefore, we treated HeLa cells with histamine and determined the effect on Golgi morphology. As shown in Fig. 6A-B , histamine treatment induced Golgi fragmentation in a dose and time dependent manner. More than 40% of cells possessed fragmented Golgi after 100 µM histamine treatment for 1 h, a concentration and time often used in previous studies (50, 51) . Subsequent EM analysis confirmed that histamine treatment induced alterations in the Golgi structure, including fewer cisternae per stack, shorter cisternae, and an increased number of Golgi-associated vesicles ( Fig. 6C-D;   Fig. S6A ).
It has been previously shown that histamine activates Gβγ, which causes TGN fragmentation (49) .
Since HeLa cells do not express Gβγ, and histamine treatment triggers fragmentation of the entire Golgi stack (Fig. 6C-D) , the Golgi fragmentation observed in our study may occur through a different mechanism. Indeed, like TG, histamine-induced Golgi fragmentation also depended on PKC, as the addition of the PKC inhibitor Gӧ6976 reduced histamine-induced Golgi fragmentation ( Fig. 6E-F) . To investigate the functional consequence of histamine treatment on Golgi function, VSV-G trafficking experiments were performed as above. As shown in Fig. S6B -C, histamine treatments slightly 11 decreased VSV-G trafficking within 45 min release, but then began to increase the trafficking speed in the Golgi at later time points. These results demonstrate that histamine treatment impacts Golgi structure and function through a similar mechanism as TG.
DISCUSSION
In this study, by comparing Golgi fragmentation with ER stress in response to TG, Tu and DTT treatments, we uncovered a novel signaling pathway through which increased cytosolic Ca 2+ triggers Golgi fragmentation through PKC activation and GRASP55 phosphorylation. Significantly, we also demonstrated that histamine modulates the Golgi structure and function via a similar mechanism, which opens a new window through which we can understand the effect of histamine on cell physiology.
One possible model of Golgi stress is that the expanding capacity of the ER during cellular stress leads to the failure of the Golgi as it is over-burdened with misfolded or improperly folded proteins, affecting its functions like glycosylation (36) . However, our results do not support this hypothesis for two reasons: First, although all three ER stress inducers, TG, Tu and DTT, all induce ER stress, only TG treatment causes Golgi fragmentation. Second, TG induces Golgi fragmentation at a low dose and time when UPR is undetectable. These results demonstrate that Golgi fragmentation occurs independent of ER stress; instead, the Golgi may possess its own mechanism to sense and respond to stress. Furthermore, our study revealed a novel mechanism that coordinates Golgi structure and perhaps function: TG treatment increases cytoplasmic Ca 2+ , which activates PKC and subsequent phosphorylation of GRASP55, impairing its function in Golgi structure formation. GRASP55 therefore provides the conceptual link between an extracellular cue and Golgi morphological change during stress.
GRASP55 is comprised of an N-terminal GRASP domain (aa1-212) that forms dimers and oligomers and functions as a membrane tether to maintain an intact Golgi structure, and an SPR domain (aa212-454) that undergoes post-translational modifications and functions as the regulatory domain of the protein (3, 5) . Originally GRASP55 was found to be phosphorylated by ERK2 at T225 and T222 (44) .
Subsequently, additional sites, such as S245 and T249, were identified to be phosphorylated in mitosis, which is required for mitotic Golgi disassembly (5) . Recently, GRASP55 was discovered to be de-O-GlcNAcylated upon energy deprivation and regulates autophagosome maturation (47) . These results indicate that GRASP55 is an excellent candidate to function as both a sensor and effector of cellular stresses. Thus, GRASP55 is likely a master regulator of Golgi structure formation, function, and stress responses.
Using GRASP55 truncation mutants we mapped the sites to the aa251-300 region in PKC-mediated phosphorylation. Expression of truncation mutants of GRASP55 that lack this region significantly reduced TG-induced Golgi fragmentation. Previously, it has been shown by mass spectrometry that GRASP55 is phosphorylated on S441 after TG treatment, but the kinase mediating this phosphorylation is unknown (52) . Although our results are consistent with this previous study, the exact phosphorylation site(s) need further investigation.
Histamine is a neuroendocrine hormone involved in the regulation of stomach acid secretion, brain function and immune response; many of these functions involve secretion (50, 51, 53) . The role of histamine in immune response is often through the activation of the downstream PKCα. For example, histamine enhances the secretion of granulocyte-macrophage colony stimulation factor (GM-CSF) and nerve growth factor (NGF) in different cell types, both through a PKCα-dependent mechanism (54).
Interestingly, histamine promotes HeLa cell proliferation and growth, and has been shown to be elevated in cancers where Golgi is fragmented and secretion is enhanced. In our experiments, histamine induced a clear Golgi fragmentation phenotype, confirming a link between histamine and Golgi fragmentation. Additionally, expression of PKCα, but not other PKC isoforms, along with a stimulation with PMA, exhibited an additive Golgi fragmentation effect. Consistent with prior work showing that disassembly of Golgi stacks accelerates protein trafficking (26), our findings therefore offer a mechanism for how histamine increases secretion of inflammatory factors.
Our study revealed that TG induces Golgi fragmentation through increasing cytosolic Ca 2+ and GRASP55 phosphorylation. A similar case has been described previously in Alzheimer's disease, where cytosolic calcium increase by Aβ treatment triggers activation of a cytosolic protease, calpain, which cleaves p35 to generate p25 and activate Cdk5, a cytoplasmic kinase that is highly expressed in neurons (55) . Subsequently, activated Cdk5 phosphorylates GRASP65 and perhaps other Golgi structural proteins, leading to Golgi fragmentation (13) . Although PKC and GRASP55 were not the focus in this study, expression of a phosphorylation deficient mutant of GRASP55 significantly reduced Golgi fragmentation as well as Aβ production. Taken together, our studies indicate that the Golgi is sensitive to cellular stimuli and stresses as in disease conditions, and responds to signaling cues to adjust its structure and function through increasing cytosolic Ca 2+ and GRASP55 modification.
Future studies defining the detailed mechanisms may help understand disease pathologies with Golgi and trafficking defects. 
MATERIALS AND METHODS
Reagents, Plasmids and siRNA
Cell Culture and Drug Treatments
For all experiments, mycoplasma-free HeLa cells were obtained from ATCC (Manassas, VA) and passaged ≤20 times prior to use in experiments. HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM; ThermoFisher, Waltham, MA) supplemented with 10% fetal bovine serum (FBS; Gemini Bio-Products, Sacramento, CA) and 100 units/ml penicillin-streptomycin at 37°C with 5% CO2. Cells were grown on glass coverslips according to standard tissue culture methods.
Coverslips were pre-coated with poly-lysine (Gibco) to aid in cell attachment. For EGTA treatment, an excess of EGTA (8.96 mM) was combined with growth medium and applied to cells 1 h prior to TG treatment, as previously described (56, 57) . All drugs, except cAMP-dependent protein kinase inhibitor (PKI) that is a peptide and dissolved in water, were made in DMSO, aliquoted, and stored at -20ºC.
Stocks were diluted into working solutions of DMEM at the time of the experiment as described in the text or figure legend. Upon the addition of the drug, cells were incubated at 5% CO2 and 37°C for the indicated times. Cells were washed 3 times with ice cold phosphate buffered saline (PBS) and collected with a cell scraper.
Immunofluorescence Microscopy
For fluorescence microscopy, cells were rinsed 3 times in ice cold PBS, fixed with 4% (w/v) To quantify Golgi fragmentation, cells were evaluated by eye under a microscope according to predefined fragmentation criteria, at least 300 cells were counted in each reaction. In experiments where transfected proteins were employed, only transfected cells were counted, and 100 cells were counted per replicate. Hoechst was used to identify individual, mitotic and overlapping cells. Briefly, cells having ≥3 disconnected Golgi items were considered fragmented, and cells with <3 were considered intact. In experiments where an inhibitor screen was performed, an unbiased image thresholding method was used to extract fragmentation data from ≥40 cells per replicate.
Electron Microscopy (EM)
For EM, cells were fixed in pre-warmed serum-free DMEM, 20 mM HEPES, pH 7.4, 2% glutaraldehyde at room temperature for 30 min or 4°C overnight as previously described (59) . Cells were washed 2 times with 0.1 M Sodium cacodylate (Electron Microscopy Sciences, Hatfield, PA), and post-fixed on ice in 1% v/v reduced Osmium tetroxide, 0.1 M Sodium cacodylate (w/v) and 1.5% cyanoferrate (w/v) in water. Cells were rinsed 3 times with 50 mM maleate buffer, pH 5.2, 3 times with water, scraped, and pelleted in microcentrifuge tubes for embedding. The EMBED 812 (EMD) protocol was used to embed cells and resin blocks were sectioned to 60 nm with a diamond knife and mounted on Formvar-coated copper grids. Samples were double contrasted with 2% uranyl acetate then with lead citrate and rinsed with copious amounts of water. Grids were imaged using a Philips (Amsterdam, Netherlands) transmission electron microscope. Golgi images were captured at 11,000x magnification. Golgi stacks were identified using morphological criteria and quantified using standard stereological techniques. A Golgi cisterna was identified as a perinuclear membrane within a Golgi stack ≥4 times longer than its width. Stack length was measured for the longest cisterna within a Golgi stack using the ruler tool in Photoshop Elements 13. For the number of cisternae per stack, the number of cisternae was counted. For the number of vesicles per stack, round objects no greater than 80 µm in diameter within 0.5 µm of a Golgi stack were counted. At least 20 cells were quantified in each experiment, and the EM results represent two independent experiments.
Protein Biochemistry and Antibodies
For immunoblotting, cells from a 10 cm dish were pelleted and lysed with 30 µl lysis buffer (20 nM Tris-HCl, 150 mM NaCl, 1% Triton X-100 (Bio-Rad, Hercules, CA), 20 mM beta-glycerol phosphate and protease inhibitors cocktail, NaF, NaVan, pH 8.0). Samples were made with 6X SDS PAGE buffer with fresh DTT, denatured at 95°C for 4 min and then run on PAGE gels. Protein was transferred to nitrocellulose membranes using semi-dry transfer at constant 16 V. Membranes were blocked for 10 min with 3% milk in 0.2% Tween-20 in phosphate buffered saline (PBST) and immunoblotted. The 
